-
1
-
-
0038119701
-
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
-
R. J. Johnson, D.-H. Kang, D. Feig et al., "Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?" Hypertension, vol. 41, no. 6, pp. 1183-1190, 2003.
-
(2003)
Hypertension
, vol.41
, Issue.6
, pp. 1183-1190
-
-
Johnson, R.J.1
Kang, D.-H.2
Feig, D.3
-
2
-
-
41349103917
-
SLC2A9 is a newly iden-tified urate transporter infuencing serum urate concentration, urate excretion and gout
-
V. Vitart, I. Rudan, C. Hayward et al., "SLC2A9 is a newly iden-tified urate transporter infuencing serum urate concentration, urate excretion and gout," Nature Genetics, vol. 40, no. 4, pp. 437-442, 2008.
-
(2008)
Nature Genetics
, vol.40
, Issue.4
, pp. 437-442
-
-
Vitart, V.1
Rudan, I.2
Hayward, C.3
-
3
-
-
33744487887
-
Uric acid and hypertension
-
D. I. Feig, D.-H. Kang, T. Nakagawa, M. Mazzali, and R. J. Johnson, "Uric acid and hypertension," Current Hypertension Reports, vol. 8, no. 2, pp. 111-115, 2006.
-
(2006)
Current Hypertension Reports
, vol.8
, Issue.2
, pp. 111-115
-
-
Feig, D.I.1
Kang, D.-H.2
Nakagawa, T.3
Mazzali, M.4
Johnson, R.J.5
-
4
-
-
0036713048
-
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity
-
S. Watanabe, D.-H. Kang, L. L. Feng et al., "Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity," Hypertension, vol. 40, no. 3, pp. 355-360, 2002.
-
(2002)
Hypertension
, vol.40
, Issue.3
, pp. 355-360
-
-
Watanabe, S.1
Kang, D.-H.2
Feng, L.L.3
-
5
-
-
0036535361
-
Uric acid and cardiovascular risk
-
M. H. Alderman, "Uric acid and cardiovascular risk," Current Opinion in Pharmacology, vol. 2, no. 2, pp. 126-130, 2002.
-
(2002)
Current Opinion in Pharmacology
, vol.2
, Issue.2
, pp. 126-130
-
-
Alderman, M.H.1
-
6
-
-
33646376660
-
Uric acid and endothelial dysfunction in essential hypertension
-
C. Zoccali, R. Maio, F. Mallamaci, G. Sesti, and F. Perticone, "Uric acid and endothelial dysfunction in essential hypertension," Journal of the American Society of Nephrology, vol. 17, no. 5, pp. 1466-1471, 2006.
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.5
, pp. 1466-1471
-
-
Zoccali, C.1
Maio, R.2
Mallamaci, F.3
Sesti, G.4
Perticone, F.5
-
7
-
-
84876913617
-
Beyond gout: Uric acid and cardiovascular diseases
-
E. Agabiti-Rosei and G. Grassi, "Beyond gout: uric acid and cardiovascular diseases," Current Medical Research and Opinion, vol. 29, no. 3, pp. 33-39, 2013.
-
(2013)
Current Medical Research and Opinion
, vol.29
, Issue.3
, pp. 33-39
-
-
Agabiti-Rosei, E.1
Grassi, G.2
-
8
-
-
0037461111
-
Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging
-
S. D. Anker, W. Doehner, M. Rauchhaus et al., "Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging," Circulation, vol. 107, no. 15, pp. 1991-1997, 2003.
-
(2003)
Circulation
, vol.107
, Issue.15
, pp. 1991-1997
-
-
Anker, S.D.1
Doehner, W.2
Rauchhaus, M.3
-
9
-
-
20244365646
-
Hyperuricemia induces endothelial dysfunction
-
U. M. Khosla, S. Zharikov, J. L. Finch et al., "Hyperuricemia induces endothelial dysfunction," Kidney International, vol. 67, no. 5, pp. 1739-1742, 2005.
-
(2005)
Kidney International
, vol.67
, Issue.5
, pp. 1739-1742
-
-
Khosla, U.M.1
Zharikov, S.2
Finch, J.L.3
-
10
-
-
0037024270
-
Efects of xan-thine oxidase inhibition with allopurinol on endothelial function and peripheral blood fow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies
-
W. Doehner, N. Schoene, M. Rauchhaus et al., "Efects of xan-thine oxidase inhibition with allopurinol on endothelial function and peripheral blood fow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies," Circulation, vol. 105, no. 22, pp. 2619-2624, 2002.
-
(2002)
Circulation
, vol.105
, Issue.22
, pp. 2619-2624
-
-
Doehner, W.1
Schoene, N.2
Rauchhaus, M.3
-
11
-
-
0042334471
-
Hyperuricemia in childhood primary hypertension
-
D. I. Feig and R. J. Johnson, "Hyperuricemia in childhood primary hypertension," Hypertension, vol. 42, no. 3, pp. 247-252, 2003.
-
(2003)
Hypertension
, vol.42
, Issue.3
, pp. 247-252
-
-
Feig, D.I.1
Johnson, R.J.2
-
12
-
-
33845748648
-
The role of uric acid in pediatric hypertension
-
D. I. Feig and R. J. Johnson, "Te role of uric acid in pediatric hypertension," Journal of Renal Nutrition, vol. 17, no. 1, pp. 79-83, 2007.
-
(2007)
Journal of Renal Nutrition
, vol.17
, Issue.1
, pp. 79-83
-
-
Feig, D.I.1
Johnson, R.J.2
-
13
-
-
54949100735
-
Uric acid and cardiovascular risk
-
D. I. Feig, D.-H. Kang, and R. J. Johnson, "Uric acid and cardiovascular risk," The New England Journal of Medicine, vol. 359, no. 17, pp. 1811-1821, 2008.
-
(2008)
The New England Journal of Medicine
, vol.359
, Issue.17
, pp. 1811-1821
-
-
Feig, D.I.1
Kang, D.-H.2
Johnson, R.J.3
-
14
-
-
84862776730
-
2+ exchanger-mediated mitochondrial calcium overload
-
2+ exchanger-mediated mitochondrial calcium overload," Cell Calcium, vol. 51, no. 5, pp. 402-410, 2012.
-
(2012)
Cell Calcium
, vol.51
, Issue.5
, pp. 402-410
-
-
Hong, Q.1
Qi, K.2
Feng, Z.3
-
15
-
-
80054055235
-
Uric acid as a mediator of diabetic nephropathy
-
D. I. Jalal, D. M. Maahs, P. Hovind, and T. Nakagawa, "Uric acid as a mediator of diabetic nephropathy," Seminars in Nephrology, vol. 31, no. 5, pp. 459-465, 2011.
-
(2011)
Seminars in Nephrology
, vol.31
, Issue.5
, pp. 459-465
-
-
Jalal, D.I.1
Maahs, D.M.2
Hovind, P.3
Nakagawa, T.4
-
16
-
-
34249902290
-
Uric acid: An old actor for a new role
-
E. Manzato, "Uric acid: an old actor for a new role," Internal and Emergency Medicine, vol. 2, no. 1, pp. 1-2, 2007.
-
(2007)
Internal and Emergency Medicine
, vol.2
, Issue.1
, pp. 1-2
-
-
Manzato, E.1
-
17
-
-
84871733357
-
Uric acid as a danger signal in gout and its comorbidities
-
K. L. Rock, H. Kataoka, and J.-J. Lai, "Uric acid as a danger signal in gout and its comorbidities," Nature Reviews Rheumatology, vol. 9, no. 1, pp. 13-23, 2013.
-
(2013)
Nature Reviews Rheumatology
, vol.9
, Issue.1
, pp. 13-23
-
-
Rock, K.L.1
Kataoka, H.2
Lai, J.-J.3
-
18
-
-
79956335244
-
Elevated serum uric acid is associated with high circulating infammatory cytokines in the population-based colaus study
-
Article e19901
-
T. Lyngdoh, P. Marques-Vidal, F. Paccaud et al., "Elevated serum uric acid is associated with high circulating infammatory cytokines in the population-based colaus study," PLoS ONE, vol. 6, no. 5, article e19901, 2011.
-
(2011)
PLoS ONE
, vol.6
, Issue.5
-
-
Lyngdoh, T.1
Marques-Vidal, P.2
Paccaud, F.3
-
19
-
-
27744453362
-
Understanding RAGE, the receptor for advanced glycation end products
-
A. Bierhaus, P. M. Humpert, M. Morcos et al., "Understanding RAGE, the receptor for advanced glycation end products," Journal of Molecular Medicine, vol. 83, no. 11, pp. 876-886, 2005.
-
(2005)
Journal of Molecular Medicine
, vol.83
, Issue.11
, pp. 876-886
-
-
Bierhaus, A.1
Humpert, P.M.2
Morcos, M.3
-
20
-
-
0344286498
-
Activation of receptor for advanced glycation end products-a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
-
A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern, "Activation of receptor for advanced glycation end products-a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis," Circulation Research, vol. 84, no. 5, pp. 489-497, 1999.
-
(1999)
Circulation Research
, vol.84
, Issue.5
, pp. 489-497
-
-
Schmidt, A.M.1
Yan, S.D.2
Wautier, J.-L.3
Stern, D.4
-
21
-
-
0033552883
-
Atherosclerosis-an infammatory disease-reply
-
R. Ross, "Atherosclerosis-an infammatory disease-reply," The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999.
-
(1999)
The New England Journal of Medicine
, vol.340
, Issue.2
, pp. 115-126
-
-
Ross, R.1
-
22
-
-
33746920337
-
Advanced glycation end products: Sparking the development of diabetic vascular injury
-
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager, "Advanced glycation end products: sparking the development of diabetic vascular injury," Circulation, vol. 114, no. 6, pp. 597-605, 2006.
-
(2006)
Circulation
, vol.114
, Issue.6
, pp. 597-605
-
-
Goldin, A.1
Beckman, J.A.2
Schmidt, A.M.3
Creager, M.A.4
-
23
-
-
52749084063
-
Receptor for advanced glycation end products (RAGE) defciency attenuates the development of atherosclerosis in diabetes
-
A. Soro-Paavonen, A. M. D. Watson, J. Li et al., "Receptor for advanced glycation end products (RAGE) defciency attenuates the development of atherosclerosis in diabetes," Diabetes, vol. 57, no. 9, pp. 2461-2469, 2008.
-
(2008)
Diabetes
, vol.57
, Issue.9
, pp. 2461-2469
-
-
Soro-Paavonen, A.1
Watson, A.M.D.2
Li, J.3
-
24
-
-
77950898257
-
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
-
S. F. Yan, R. Ramasamy, and A. M. Schmidt, "Te RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature," Circulation Research, vol. 106, no. 5, pp. 842-853, 2010.
-
(2010)
Circulation Research
, vol.106
, Issue.5
, pp. 842-853
-
-
Yan, S.F.1
Ramasamy, R.2
Schmidt, A.M.3
-
25
-
-
0037133280
-
Advanced glyca-tion end products activate endothelium through signal-trans-duction receptor RAGE: A mechanism for amplification of infammatory responses
-
G. Basta, G. Lazzerini, M. Massaro et al., "Advanced glyca-tion end products activate endothelium through signal-trans-duction receptor RAGE: a mechanism for amplification of infammatory responses," Circulation, vol. 105, no. 7, pp. 816-822, 2002.
-
(2002)
Circulation
, vol.105
, Issue.7
, pp. 816-822
-
-
Basta, G.1
Lazzerini, G.2
Massaro, M.3
-
26
-
-
26444436438
-
The rage axis and endothelial dysfunction: Maladaptive roles in the diabetic vasculature and beyond
-
R. Ramasamy, S. F. Yan, and A. M. Schmidt, "Te rage axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond," Trends in Cardiovascular Medicine, vol. 15, no. 7, pp. 237-243, 2005.
-
(2005)
Trends in Cardiovascular Medicine
, vol.15
, Issue.7
, pp. 237-243
-
-
Ramasamy, R.1
Yan, S.F.2
Schmidt, A.M.3
-
27
-
-
1542375215
-
HMGB1, a pro-infammatory cytokine of clinical interest: Introduction
-
U. G. Andersson and K. J. Tracey, "HMGB1, a pro-infammatory cytokine of clinical interest: introduction," Journal of Internal Medicine, vol. 255, no. 3, pp. 318-319, 2004.
-
(2004)
Journal of Internal Medicine
, vol.255
, Issue.3
, pp. 318-319
-
-
Andersson, U.G.1
Tracey, K.J.2
-
28
-
-
0033538467
-
HMG-1 as a late mediator of endotoxin lethality in mice
-
H. C. Wang, O. Bloom, M. H. Zhang et al., "HMG-1 as a late mediator of endotoxin lethality in mice," Science, vol. 285, no. 5425, pp. 248-251, 1999.
-
(1999)
Science
, vol.285
, Issue.5425
, pp. 248-251
-
-
Wang, H.C.1
Bloom, O.2
Zhang, M.H.3
-
29
-
-
84860155576
-
Inhibitory effects of lycopene on HMGB1-mediated pro-infammatory responses in both cellular and animal models
-
W. Lee, S.-K. Ku, J. W. Bae, and J.-S. Bae, "Inhibitory effects of lycopene on HMGB1-mediated pro-infammatory responses in both cellular and animal models," Food and Chemical Toxicology, vol. 50, no. 6, pp. 1826-1833, 2012.
-
(2012)
Food and Chemical Toxicology
, vol.50
, Issue.6
, pp. 1826-1833
-
-
Lee, W.1
Ku, S.-K.2
Bae, J.W.3
Bae, J.-S.4
-
30
-
-
84858251415
-
Interaction between uric acid and HMGB1 translocation and release from endothe-lial cells
-
M. M. Rabadi, M.-C. Kuo, T. Ghaly et al., "Interaction between uric acid and HMGB1 translocation and release from endothe-lial cells," American Journal of Physiology-Renal Physiology, vol. 302, no. 6, pp. F730-F741, 2012.
-
(2012)
American Journal of Physiology-Renal Physiology
, vol.302
, Issue.6
, pp. F730-F741
-
-
Rabadi, M.M.1
Kuo, M.-C.2
Ghaly, T.3
-
31
-
-
25644447521
-
Pathogenesis of gout
-
H. K. Choi, D. B. Mount, and A. M. Reginato, "Pathogenesis of gout," Annals of Internal Medicine, vol. 143, no. 7, pp. 499-516, 2005.
-
(2005)
Annals of Internal Medicine
, vol.143
, Issue.7
, pp. 499-516
-
-
Choi, H.K.1
Mount, D.B.2
Reginato, A.M.3
-
32
-
-
33646545069
-
Hyperuricemia and associated diseases
-
M. A. Becker and M. Jolly, "Hyperuricemia and associated diseases," Rheumatic Disease Clinics of North America, vol. 32, no. 2, pp. 275-293, 2006.
-
(2006)
Rheumatic Disease Clinics of North America
, vol.32
, Issue.2
, pp. 275-293
-
-
Becker, M.A.1
Jolly, M.2
-
33
-
-
75749130719
-
Hyperuricemia and coronary heart disease: A systematic review and meta-analysis
-
Y. S. Kim, J. P. Guevara, K. M. Kim, H. K. Choi, D. F. Heitjan, and D. A. Albert, "Hyperuricemia and coronary heart disease: a systematic review and meta-analysis," Arthritis Care & Research, vol. 62, no. 2, pp. 170-180, 2010.
-
(2010)
Arthritis Care & Research
, vol.62
, Issue.2
, pp. 170-180
-
-
Kim, Y.S.1
Guevara, J.P.2
Kim, K.M.3
Choi, H.K.4
Heitjan, D.F.5
Albert, D.A.6
-
34
-
-
84892837210
-
Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies
-
M. Li, W. Hou, X. Zhang, L. Hu, and Z. Tang, "Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies," Atherosclerosis, vol. 232, no. 2, pp. 265-270, 2014.
-
(2014)
Atherosclerosis
, vol.232
, Issue.2
, pp. 265-270
-
-
Li, M.1
Hou, W.2
Zhang, X.3
Hu, L.4
Tang, Z.5
-
35
-
-
0037324283
-
Endothelial dysfunction-a marker of atherosclerotic risk
-
P. O. Bonetti, L. O. Lerman, and A. Lerman, "Endothelial dysfunction-a marker of atherosclerotic risk," Arteriosclerosis, Trombosis, and Vascular Biology, vol. 23, no. 2, pp. 168-175, 2003.
-
(2003)
Arteriosclerosis, Trombosis, and Vascular Biology
, vol.23
, Issue.2
, pp. 168-175
-
-
Bonetti, P.O.1
Lerman, L.O.2
Lerman, A.3
-
36
-
-
2942733214
-
Role of endothelial dysfunction in atherosclerosis
-
J. Davignon and P. Ganz, "Role of endothelial dysfunction in atherosclerosis," Circulation, vol. 109, no. 23, supplement 1, pp. III27-III32, 2004.
-
(2004)
Circulation
, vol.109
, Issue.23
, pp. III27-III32
-
-
Davignon, J.1
Ganz, P.2
-
37
-
-
84870766457
-
Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations
-
L. G. Sánchez-Lozada, M. A. Lanaspa, M. Cristóbal-García et al., "Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations," Nephron-Experimental Nephrology, vol. 121, no. 3-4, pp. e71-e78, 2013.
-
(2013)
Nephron-Experimental Nephrology
, vol.121
, Issue.3-4
, pp. e71-e78
-
-
Sánchez-Lozada, L.G.1
Lanaspa, M.A.2
Cristóbal-García, M.3
-
38
-
-
33744483767
-
Uric acid and the vasculature
-
D. B. Corry and M. L. Tuck, "Uric acid and the vasculature," Current Hypertension Reports, vol. 8, no. 2, pp. 116-119, 2006.
-
(2006)
Current Hypertension Reports
, vol.8
, Issue.2
, pp. 116-119
-
-
Corry, D.B.1
Tuck, M.L.2
-
39
-
-
84860470278
-
The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular mechanisms and clinical implications
-
P. Puddu, G. M. Puddu, E. Cravero, L. Vizioli, and A. Muscari, "Te relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications," Journal of Cardiology, vol. 59, no. 3, pp. 235-242, 2012.
-
(2012)
Journal of Cardiology
, vol.59
, Issue.3
, pp. 235-242
-
-
Puddu, P.1
Puddu, G.M.2
Cravero, E.3
Vizioli, L.4
Muscari, A.5
-
40
-
-
84942133560
-
Association between the advanced glycosylation end product-specifc receptor gene and cardiovascular death in older men
-
Article ID e0134475
-
E. Biros, C. S. Moran, P. E. Norman et al., "Association between the advanced glycosylation end product-specifc receptor gene and cardiovascular death in older men," PLoS ONE, vol. 10, no. 7, Article ID e0134475, 2015.
-
(2015)
PLoS ONE
, vol.10
, Issue.7
-
-
Biros, E.1
Moran, C.S.2
Norman, P.E.3
-
41
-
-
84890980055
-
Unlocking the biology of RAGE in diabetic microvascular complications
-
M. B. Manigrasso, J. Juranek, R. Ramasamy, and A. M. Schmidt, "Unlocking the biology of RAGE in diabetic microvascular complications," Trends in Endocrinology & Metabolism, vol. 25, no. 1, pp. 15-22, 2014.
-
(2014)
Trends in Endocrinology & Metabolism
, vol.25
, Issue.1
, pp. 15-22
-
-
Manigrasso, M.B.1
Juranek, J.2
Ramasamy, R.3
Schmidt, A.M.4
-
42
-
-
63849340999
-
RAGE signaling in infam-mation and arterial aging
-
L. Lin, S. Park, and E. G. Lakatta, "RAGE signaling in infam-mation and arterial aging," Frontiers in Bioscience, vol. 14, no. 4, pp. 1403-1413, 2009.
-
(2009)
Frontiers in Bioscience
, vol.14
, Issue.4
, pp. 1403-1413
-
-
Lin, L.1
Park, S.2
Lakatta, E.G.3
-
43
-
-
84943408560
-
HMGB1 and injury amplification
-
P. Huebener, C. Hernandez, and R. F. Schwabe, "HMGB1 and injury amplification," Oncotarget, vol. 6, no. 27, pp. 23048-23049, 2015.
-
(2015)
Oncotarget
, vol.6
, Issue.27
, pp. 23048-23049
-
-
Huebener, P.1
Hernandez, C.2
Schwabe, R.F.3
-
44
-
-
79952366675
-
High-mobility group box 1, oxidative stress, and disease
-
D. Tang, R. Kang, H. J. Zeh, and M. T. Lotze, "High-mobility group box 1, oxidative stress, and disease," Antioxidants and Redox Signaling, vol. 14, no. 7, pp. 1315-1335, 2011.
-
(2011)
Antioxidants and Redox Signaling
, vol.14
, Issue.7
, pp. 1315-1335
-
-
Tang, D.1
Kang, R.2
Zeh, H.J.3
Lotze, M.T.4
-
45
-
-
84907296663
-
The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation
-
D. J. Weber, A. S. Gracon, M. S. Ripsch et al., "Te HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation," Science Transla-tional Medicine, vol. 6, no. 252, pp. 5140-5144, 2014.
-
(2014)
Science Transla-tional Medicine
, vol.6
, Issue.252
, pp. 5140-5144
-
-
Weber, D.J.1
Gracon, A.S.2
Ripsch, M.S.3
-
46
-
-
38149078193
-
Vascular and infamma-tory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice
-
E. Harja, D.-X. Bu, B. I. Hudson et al., "Vascular and infamma-tory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice," The Journal of Clinical Investigation, vol. 118, no. 1, pp. 183-194, 2008.
-
(2008)
The Journal of Clinical Investigation
, vol.118
, Issue.1
, pp. 183-194
-
-
Harja, E.1
Bu, D.-X.2
Hudson, B.I.3
-
47
-
-
78049291345
-
HMGB1 activates nuclear factor-αBsignalingbyRAGE and increases the production of TNF-α in human umbilical vein endothelial cells
-
Z.-G. Luan, H. Zhang, P.-T. Yang, X.-C. Ma, C. Zhang, and R.-X. Guo, "HMGB1 activates nuclear factor-αBsignalingbyRAGE and increases the production of TNF-α in human umbilical vein endothelial cells," Immunobiology, vol. 215, no. 12, pp. 956-962, 2010.
-
(2010)
Immunobiology
, vol.215
, Issue.12
, pp. 956-962
-
-
Luan, Z.-G.1
Zhang, H.2
Yang, P.-T.3
Ma, X.-C.4
Zhang, C.5
Guo, R.-X.6
|